Influenza vaccines Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high-dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants (all ages) Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® AusVaxSafety commenced routine safety monitoring of 2024 seasonal influenza vaccines used in Australia across all ages in March 2024.The influenza vaccines in use in Australia in 2024 are:Standard influenza vaccinesAfluria® Quad (individuals aged 5 years and older)Fluarix Tetra® (individuals aged 6 months and older)Flucelvax® Quad (individuals aged 6 months and older)FluQuadri® (individuals aged 6 months and older)Influvac® Tetra (individuals aged 6 months and older)Vaxigrip Tetra® (individuals aged 6 months and older).Adjuvanted or high-dose vaccinesFluad® Quad (individuals aged 65 years and over)Fluzone® High-Dose Quad (individuals aged 60 years and over).Surveillance data are gathered via AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination. Latest influenza vaccine safety dataClick on the tiles below to view 2024 AusVaxSafety influenza vaccine safety data for specific age and population groups. Note: Additional age and population groups will be added below once enough data are collected for meaningful analysis. Influenza vaccine safety data – 6 months to younger than 5 years View the latest safety data here Influenza vaccine safety data - 5 years and older (standard vaccines) View the latest safety data here Influenza vaccine safety data – 60 years and older (adjuvanted or high-dose vaccine) View the latest safety data here Influenza vaccine safety data – pregnant participants View the latest safety data here Influenza vaccine safety data – Aboriginal and Torres Strait Islander participants (all ages) View the latest safety data here Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high-dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants (all ages) Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® News & events All news & events 02 July 2024 | News Call for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccination 28 March 2024 | News AusVaxSafety commences routine surveillance of 2024 seasonal influenza vaccines 08 March 2024 | News Vaccine safety in Australia AusVaxSafety summary report now available 20 February 2024 | News What to expect in the days after your XBB.1.5 COVID-19 vaccine